Developing a PrEP Adherence Intervention Targeting At-Risk and Substance Using Women

Completed · Not applicable

Conditions studied: HIV/AIDS

In brief

The purpose of this study is to develop and assess the feasibility, acceptability, and preliminary efficacy on adherence of a community-informed intervention for tenofovir/emtricitabine (TDF/FTC) pre-exposure prophylaxis (PrEP) engagement among street-based female sex workers (FSW) in Baltimore, Maryland.

Key facts

Study ID

NCT04396678

Run by

Johns Hopkins Bloomberg School of Public Health

People needed

39

Starts

2019-06-12

Expected to finish

2020-12-01

Last updated by the study team

2021-08-31

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Age 18 or older
• Assigned female at birth and identify as a woman
• Traded sex for money or drugs at least three times in the past three months
• HIV negative
• Willing to initiate PrEP
• Not knowingly pregnant or planning to become pregnant during the following 6 months.

You may not qualify if…

• Currently taking PrEP for HIV prevention
• Inability to provide informed consent in English
• Women who are determined as too high or drunk
• Women who are cognitively impaired
• Does not agree to data sharing with the Baltimore City Health Department

Where it is running

• SPARC Center — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.